Meghana Chalasani

Tweets are my own. Follows/Retweet ≠ endorsement.

[FDA Drugs and Biologics @FDADrugs]

FDA releases white paper on Selective Safety Data Collection. SSDC is the planned reduction in certain data collection for drugs with well-characterized safety profiles. White paper discusses trials that have used SSDC in oncology & cardiometabolic spaces. https://t.co/KXm381zOqE

[FDA Drugs and Biologics @FDADrugs]

The CDER Center for Clinical Trial Innovation (C3TI) demonstration project on Bayesian methods is expanding its scope to include pre-specified primary analysis and trial monitoring, in addition to its previous focus on supplementary analysis. Learn more: https://t.co/5TZbfLKrHJ

[FDA Drugs and Biologics @FDADrugs]

Have you subscribed to our Center for Clinical Trial Innovation updates yet?

Click on https://t.co/BIqNqV7Lsd, and then click 'Subscribe to Email Updates' at the top of the page. Enter your email address to receive timely updates on innovative approaches to clinical trials.

[U.S. FDA @FDA]

Today is Clinical Trials Day! We remain committed to supporting clinical research including engaging patients and caregivers to understand their unique perspectives to promote innovative clinical trial design. #FDAVoices https://t.co/74zoHwnQoL

[FDA Drugs and Biologics @FDADrugs]

Today, we announced the launch of the CDER Center for Clinical Trial Innovation (C3TI). C3TI’s mission is to promote CDER clinical trial innovation activities through enhanced communication and collaboration, both internally within CDER and externally: https://t.co/ilPEPlOb5e

[FDA Drugs and Biologics @FDADrugs]

FDA is extending the nomination deadline for academicians and clinicians to serve as members of the new Genetic Metabolic Diseases Advisory Committee to March 12, 2024.

Submit a nomination: https://t.co/XjuilXKcKu

[FDA Drugs and Biologics @FDADrugs]

Join FDA, with @DukeMargolis, for a hybrid public workshop to discuss efforts to advance innovation of clinical trial design and conduct.

📅 March 19 & 20 both on-site and virtual

Learn more & register➡️https://t.co/pG5AuwAI7K

[FDA Drugs and Biologics @FDADrugs]

❔ Have ideas on how to innovate clinical trials to overcome barriers? Help shape the future of clinical trial design by commenting on the FDA docket.

💬 Learn more: https://t.co/bOGnvIVTGf

#RareDisease

[Meghana Chalasani @M_Chalasani]

Please share with your networks and encourage relevant experts to apply! FDA is accepting applications until February 11, 2024.

[FDA Drugs and Biologics @FDADrugs]

Today, FDA is announcing a new Genetic Metabolic Diseases Advisory Committee (GeMDAC) to help the agency explore the complex issues related to genetic metabolic disease drug development: https://t.co/alW2fNRSF3

[U.S. FDA @FDA]

Today, we announced the agency is creating a new advisory committee related to potential treatments for genetic metabolic diseases. https://t.co/W6wsj5h88b

[FDA Drugs and Biologics @FDADrugs]

To understand the state of innovation in clinical trial design and conduct, CDER is soliciting public comments and gathering information on the barriers and facilitators to incorporating innovative clinical trial approaches in drug development programs: https://t.co/bOGnvIVTGf

[Montgomery County MD Government @MontgomeryCoMD]

👗 @MoCoRec is collecting gently used and new dresses, suits and accessories students will be able to choose from during “Project Prom Dress,” a giveaway event on Saturday, April 15, at Praisner Community Recreation Center in Burtonsville. Details ➡️ https://t.co/h5Y2yuxG2s.

[Positively Present @positivepresent]

Happy Thursday… 🧡

[Meghana Chalasani @M_Chalasani]

Overwhelming feeling of appreciation and gratitude today…wish you and yours a Happy Thanksgiving!

[Lauren Nephew MD, MSCE @LaurenNephewMD]

We celebrated the establishment of the Naga P. Chalasani endowed chair last night. I always knew I had an accomplished mentor, but to hear he did it all while maintaining relationships with family & friends made it all more special. Congratulations! @nagachalasani @IUGastro

[Indiana University Gastroenterology and Hepatology @IUGastro]

With the support of generous donors, the @nagachalasani Endowed Chair campaign reached $2.5 million. 🎉 Last night we were joined by friends/family to honor his lifetime of accomplishments. Thank you to @rajVuppaLanchi and Dr. Ghabril for co-chairing the campaign. #LiverTwitter

[Meghana Chalasani @M_Chalasani]

Happy #NationalDogDay, Jade! 🐶❤️

[Meghana Chalasani @M_Chalasani]

Congrats @nagachalasani!!! 👏🏽👏🏽👏🏽Immensely proud of you for your hard work, dedication, ability to inspire all those around you, and of course, this tremendous honor! ❤️

[Indiana University Gastroenterology and Hepatology @IUGastro]

We're excited to announce the @nagachalasani Endowed Chair in Gastroenterology and Hepatology. 💪 Dr. Chalasani has served #iugastro for 15 years and his mentorship, leadership, strength and compassion for faculty, staff and anyone he comes into contact with is unmatched. 🧵⬇️

[FDA Drugs and Biologics @FDADrugs]

Join FDA and @NIH on August 24 at 3 PM ET for a virtual webinar to learn about the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS).

Register: https://t.co/UW11tjlqjz

[U.S. FDA @FDA]

Today we unveiled our ACT for ALS Action Plan, a 5-year strategy for improving & extending the lives of people living with rare neurodegenerative diseases. https://t.co/oOAckW5ygs